How much would Covid vaccines for the entire world cost?
Gordon Brown and Tony Blair among more than 100 former leaders calling for G7 to fund a global vaccination programme
The world’s richest countries should foot most of the bill for vaccinating the entire global population against Covid-19, according to a letter signed by 230 international leaders.
Gordon Brown and Tony Blair are among more than 100 former prime ministers, presidents and foreign ministers who have co-signed the written plea to the current leaders of the UK, US, France, Germany, Italy, Japan and Canada to pay two-thirds of the estimated $66bn (£46.5bn) cost.
The letter, seen by The Guardian, has been sent ahead of a three-day G7 summit being hosted by Boris Johnson in Cornwall from Friday. The newspaper reports that the powerful nations are also being urged to “lead the way on dose-sharing, voluntary licensing agreements and temporary patent waivers”, in order to boost vaccine production worldwide and help prevent new, and potentially more deadly, strains of the virus from spreading.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Under the proposals, the UK would contribute about 5% of the total cost, paying around $3bn (£2.1bn) over the next two years. That would amount to 30p per week per British citizen in return for “the best insurance policy in the world”, former Labour leader Brown told the BBC’s Today programme.
The UK is “perfectly capable of paying this sum”, said Brown, who pointed out that countries are set to receive a grant of $21bn (£15bn) each from the International Monetary Fund (IMF), in a bid to prop up Covid-stricken economies.
And for the G7 nations to use some of that money to vaccinate people in low-income countries “is not charity, it is self-protection to stop the disease spreading, mutating and returning to threaten all of us”, he added.
The IMF has also been pushing for a mass vaccination drive, outlining plans to inoculate at least 40% of the global population by the end of this year and at least 60% by July 2022. A report published by the Washington D.C-based organisation in January estimated that “faster progress on ending the health crisis will raise global income cumulatively by $9trn” by 2025.
But “much now depends on the outcome of this race between a mutating virus and vaccines to end the pandemic”, the IMF warned.
While the UK has one of the most successful vaccination programmes in the world, with more than three-quarters of adults now having received at least one dose, many other countries are lagging behind. Just 2% of people in sub-Saharan Africa have been vaccinated against Covid-19.
The proposal for G7 nations to help fund speedier rollouts has widespread support among citizens of the member states, according to a survey commissioned by Save the Children. Of more than 1,000 people polled in the UK, 79% supported the plan, with similar results from surveys in the US, France, Germany and Canada.
As world leaders head to the UK for the G7 summit in Cornwall, host Johnson yesterday pledged to urge leaders to “rise to the greatest challenge of the postwar era” by “vaccinating the world by the end of next year”.
However, while the US, France, Germany, Italy and Japan have all announced how many doses they each plan to donate to the global vaccine-sharing programme, Covax, “the UK and Canada are yet to put figures on their planned contributions”, the BBC reports.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Sorcha Bradley is a writer at The Week and a regular on “The Week Unwrapped” podcast. She worked at The Week magazine for a year and a half before taking up her current role with the digital team, where she mostly covers UK current affairs and politics. Before joining The Week, Sorcha worked at slow-news start-up Tortoise Media. She has also written for Sky News, The Sunday Times, the London Evening Standard and Grazia magazine, among other publications. She has a master’s in newspaper journalism from City, University of London, where she specialised in political journalism.
-
Trump declares 'golden age' at indoor inauguration
In the Spotlight Donald Trump has been inaugurated as the 47th president of the United States
By Justin Klawans, The Week US Published
-
Where in the world to hop on a hot air balloon
The Week Recommends Float above California vineyards, Swiss Alps and the plains of the Serengeti
By Catherine Garcia, The Week US Published
-
'The death and destruction happening in Gaza still dominate our lives'
Instant Opinion Opinion, comment and editorials of the day
By Justin Klawans, The Week US Published
-
HMPV is spreading in China but there's no need to worry
The Explainer Respiratory illness is common in winter
By Devika Rao, The Week US Published
-
Marty Makary: the medical contrarian who will lead the FDA
In the Spotlight What Johns Hopkins surgeon and commentator Marty Makary will bring to the FDA
By David Faris Published
-
Will the murder of a health insurance CEO cause an industry reckoning?
Today's Big Question UnitedHealthcare CEO Brian Thompson was shot and killed in what police believe was a targeted attack
By Justin Klawans, The Week US Published
-
What are Trump's plans for public health?
Today's Big Question From abortion access to vaccine mandates
By Devika Rao, The Week US Published
-
What went wrong at CVS?
Today's Big Question Pharmacy chains are in crisis
By Joel Mathis, The Week US Published
-
Long Covid: study shows damage to brain's 'control centre'
The Explainer Research could help scientists understand long-term effects of Covid-19 as well as conditions such as MS and dementia
By The Week UK Published
-
FDA OKs new Covid vaccine, available soon
Speed read The CDC recommends the new booster to combat the widely-circulating KP.2 strain
By Peter Weber, The Week US Published
-
Mpox: how dangerous is new health emergency?
Today's Big Question Spread of potentially deadly sub-variant more like early days of HIV than Covid, say scientists
By The Week UK Published